Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 92

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 2
Chunk 92
---
 working capital (deficit) at September 30, 2025
and December 31, 2024.

    September 30, 2025  
    December 31, 2024 

    Current
    Assets 
    $3,210,591  
    $3,352,795 

    Current
    Liabilities 
    $1,053,829  
    $613,549 

    Accumulated
    Deficit 
    $(9,585,956) 
    $(8,824,193)

    Working
    Capital 
    $2,156,762  
    $2,739,246 

8

Liquidity
is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate
on an ongoing basis. To date, we have funded our operations through equity and debt financings. Our primary uses of cash have been for
the development of operations, compensation, and professional fees. All funds received have been expended in the furtherance of growing
our business and establishing our services and solutions. The following trends are reasonably likely to result in a material decrease
in our liquidity over the near to long term:

    ●
    A
    substantial increase in working capital requirements to finance our operations;

    ●
    Addition
    of administrative and professional personnel as our business continues to grow;

    ●
    The
    cost of being a public company; and

    ●
    Payments
    for seeking and securing quality staffing personnel.

Cash
Flow Activities for the Nine Months Ended September 30, 2025 and 2024

Net
Cash Used in Operating Activities 

Cash
used provided by operating activities for the nine months ended September 30, 2025 was $158,554 and cash used in operating activities
for the nine months ended September 30, 2024 was $2,717,313. The improvement in operating cash activities is a result of our efforts
to reduce expenses and better working capital management.

Net
Cash Used in Investing Activities

Cash
used in investing activities for the nine months ended September 30, 2025 and 2024 was $0 and $11,111, respectively, which related entirely
to the purchase of property and equipment during both periods.

Net
Cash Provided by Financing Activities

Cash
used in financing activities for the nine months ended September 30, 2025 was $260,